Sponsor Pipeline

SynAct Pharma Aps Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06671054 A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in… Rheumatoid Arthritis (RA) Recruiting
NCT04456816 A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With… Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy Recruiting
NCT07633288 A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on… Respiratory Viral Infection Recruiting
Disease Areas
Rheumatoid Arthritis (1)
Get alerts when SynAct Pharma Aps's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free